Source: Annual Congress 2006 - Implications of progressive airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. K. Gavrisyuk, N. I. Gumenyuk, Y. A. Dzyublik, N. D. Morskaya (Kiev, Ukraine). Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients. Eur Respir J 2006; 28: Suppl. 50, 3667

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010 Erythropoietin in chronic obstructive pulmonary disease patients without anemia Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 Targeted therapy in eosinophilic chronic obstructive pulmonary disease Source: ERJ Open Res, 7 (2) 00437-2020; 10.1183/23120541.00437-2020 Year: 2021 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Metabolic syndrome in chronic obstructive pulmonary disease Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Chronic pain in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 Fenspiride efficacy in the treatment of chronic obstructive pulmonary disease Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Bronchodilators in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266 Year: 2006 Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Mortality in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001